Results 171 to 180 of about 462,772 (320)
Aim: To compare the effects of one year- long strontium ranelate (SR) and raloxiphene ( R) therapies on bone mineral densities (BMDs) in postmenopausal osteoporotic women.
Banu Kuran +4 more
core
Vitamin D Supplementation for Adult Long‐Term Psychiatric Inpatients
ABSTRACT Low vitamin D status is associated with various adverse physical health outcomes including osteoporosis and compromised immune functioning. Emerging research has shown that supplementation can yield selective benefit on symptomatology in serious mental illness. Despite its known benefits, vitamin D screening is not standard in psychiatric care.
G. N. Rustom +2 more
wiley +1 more source
Estimating the prevalence of osteoporosis in Australia [PDF]
This report presents information about the prevalence and impact of osteoporosis in Australians aged 50 and over. Summary Osteoporosis, a common condition among older people, causes bones to become weak.
core
ABSTRACT Purpose Despite spending more on healthcare than any other high‐income nation, the United States faces comparatively poor life expectancy outcomes, primarily due to non‐compliance with preventable and modifiable lifestyle behaviours. This review evaluates the multi‐systemic benefits of physical activity, exercise, diet, weight management and ...
Darah Dilmaghani +2 more
wiley +1 more source
The Effect of Yoga Education on Balance and Quality of Life in Postmenopausal Osteoporosis
Osteoporotic vertebra and hip fractures are major cause of dysfunction, disability, mortality and loss of life quality in our growing and ageing population.
Sevtap Sipahi +4 more
core
Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review
ABSTRACT Background Chronic kidney disease (CKD) associated osteoporosis leads to an increased risk of bone fracture in patients with CKD. Evidence on the efficacy and safety of anti‐osteoporotic medications is limited for this group. This systematic review aimed to examine the efficacy and safety of anabolic parathyroid hormone (PTH) treatment in ...
Huriye Seyma Kafa +2 more
wiley +1 more source
A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis [PDF]
Osteoporosis is a major cause of morbidity, mortality and resource cost amongst the elderly population. Hip fracture is the most serious of the osteoporotic fractures, with approximately 10-20% of patients dying within six months of sustaining a fracture.
Bernie O'Brien +3 more
core
Women with obesity exhibited higher total and site‐specific BMD and greater lean mass than lean controls. However, reduced BMD‐to‐fat and lean‐to‐fat mass ratios, increased CTX1 and RANK‐L/OPG, and decreased P1NP and osteocalcin indicated impaired bone remodeling, suggesting that increased BMD masks altered bone turnover and compromised skeletal health.
Yasmin Silva Forte +8 more
wiley +1 more source
GCs reduce Parkin, leading to ACSL4 accumulation and PUFA‐phospholipid‐driven ferroptosis in BMSCs, which impairs osteogenesis and promotes adipogenesis, causing GIOP. Parkin restoration (via OE‐Parkin or Parkin‐LNP@DSS6) ubiquitinates and degrades ACSL4, inhibiting ferroptosis, rescuing bone formation, and rescues GIOP bone loss.
Li‐jiang Han +16 more
wiley +1 more source
Management of postmenopausal osteoporosis.
Osteoporosis (OP) is a systemic skeletal disease characterised by low bone mass and micro-architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Common sites of osteoporotic fractures are in the spine (vertebral), hip (proximal femur) or wrist (distal forearm).
Yeap SS, Hew FL, Chan SP
openaire +2 more sources

